Back to AAVXF

Vestal Point Capital, LP → AAVXF

Vestal Point Capital, LP AAVXF Position History

ABIVAX Société Anonyme • Healthcare

Quarters held
4
Latest value
$392.1M
Q3 2026
Peak value
$392.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$256.2M
Q1 2026$167M
Q2 2026$313.1M
Q3 2026$392.1M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$392.1M3.96M——
Q2 2026$313.1M2.35M——
Q1 2026$167M1.50M——
Q4 2025$256.2M1.90M——

Other funds holding AAVXF

Other Vestal Point Capital, LP positions

NBIX

Neurocrine Biosciences Inc

$354.6M
BMRN

BioMarin Pharmaceutical Inc

$344.8M
BMRN

BioMarin Pharmaceutical Inc

$331.5M
NBIX

Neurocrine Biosciences Inc

$316.8M
ARWR

Arrowhead Pharmaceuticals Inc

$315.1M
INSM

Insmed Inc

$311M
UTHR

United Therapeutics Corp

$257.4M
UTHR

United Therapeutics Corp

$235.7M